SCHEMBL30554309

SCHEMBL30554309

O=C(c1ccncc1)c1ccc(F)nc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.52
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.43
NAPRT Q6XQN6 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
PDE4B Q07343 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MPO P05164 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6835503 1.00 LTA4H (0.52) LTA4HKMT2AMEN1LMNANAPRT
SCHEMBL1513017 0.84 AKR1C3 (0.47) KMT2AMEN1LMNAL3MBTL1ALDH1A1
SCHEMBL23458451 0.75 NAPRT (0.59) LTA4HKMT2AMEN1LMNANAPRT
SCHEMBL29551348 0.72 NAPRT (0.50) NAPRTALDH1A1KDM4ECYP1A2TSHR
SCHEMBL445478 0.72 NAPRT (0.50) NAPRTALDH1A1KDM4ECYP1A2TSHR
SCHEMBL8801902 0.71 LTA4H (0.61) LTA4HKMT2AMEN1LMNANAPRT
SCHEMBL447058 0.71 ALDH1A1 (0.43) NAPRTALDH1A1RAB9A
SCHEMBL30934037 0.71 ALDH1A1 (0.43) NAPRTALDH1A1RAB9A
SCHEMBL30506330 0.71 SMN1; SMN2 (0.40) KMT2AMEN1NAPRTL3MBTL1ALDH1A1
SCHEMBL30641935 0.71 DGAT1 (0.42) KMT2AMEN1ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112020357-B Salt of indazolyl-containing tricyclic derivative and crystal form thereof 上海翰森生物医药科技有限公司 2023-08-29 CN disclosed